Literature DB >> 6270086

Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2.

S Eriksson, D W Martin.   

Abstract

Ribonucleotide reductase is responsible for the production of the deoxyribonucleotides required for DNA synthesis. The enzyme is composed of two dissociable subunits, proteins M1 and M2, which are inactive alone, but are fully active when combined. From mouse S49 T lymphoma cells we have isolated and separated the two subunits and used each for determining the activity of the complementary subunit in extracts from cells of different phases in the cell cycle. Treatment of S49 cells with cAMP analogs (e.g. Bt2cAMP) results in the protein kinase-dependent arrest of the cells in the G1 phase of the cell cycle. Ribonucleotide reductase (holoenzyme) activity fell in S49 cells treated for more than 16 h with Bt2cAMP but was unchanged during short term treatments. The activity of protein M2 was decreased in parallel to the overall activity of ribonucleotide reductase, while protein M1 activity changed less. Removal of bt2cAMP after 24 h exposure resulted in increased holoenzyme and protein M2 activities. Centrifugal elutriation of exponentially growing S49 cells separated cells into a 90% pure G1 cell population a mixture of G1 and early S phase cells and a 95% pure S phase/G2 cell population. The specific catalytic activity of protein M1 was the same in all these fractions while that of protein M2 was decreased 60% in the G1 cell population. These results demonstrate that the ribonucleotide reduction necessary for DNA synthesis is regulated in a cell cycle-dependent fashion by the activity of the protein M2 subunit of ribonucleotide reductase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Synergistic and coordinate expression of the genes encoding ribonucleotide reductase subunits in Swiss 3T3 cells: effect of multiple signal-transduction pathways.

Authors:  D A Albert; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae.

Authors:  Andrei Chabes; Bruce Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

Authors:  Soukaina Réjiba; Christelle Bigand; Céline Parmentier; Amor Hajri
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  The small subunit of ribonucleotide reductase is encoded by one of the most abundant translationally regulated maternal RNAs in clam and sea urchin eggs.

Authors:  N M Standart; S J Bray; E L George; T Hunt; J V Ruderman
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

5.  Control of thymidine kinase mRNA during the cell cycle.

Authors:  D L Coppock; A B Pardee
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase.

Authors:  M B Slabaugh; C K Mathews
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Xu Wang; Jonathan E Zuckerman; Chung Hang J Choi; Bingsen Zhou; Dongsheng Wang; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Zhuo Georgia Chen; Yun Yen; Mark E Davis; Dong M Shin
Journal:  J Control Release       Date:  2012-02-08       Impact factor: 9.776

8.  Chromosome-mediated gene transfer of hydroxyurea resistance and amplification of ribonucleotide reductase activity.

Authors:  W H Lewis; P R Srinivasan
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

9.  Isolation of a Saccharomyces cerevisiae mutant strain deficient in deoxycytidylate deaminase activity and partial characterization of the enzyme.

Authors:  E M McIntosh; R H Haynes
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

10.  Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.

Authors:  S D Malley; J M Grange; F Hamedi-Sangsari; J R Vila
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.